🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
08777
CAS Number:
200203-20-9
Protéine tat du VIH-1 (1-9)
Synonym(s):
H-Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu-OH
Temperature Sensitive
Documents
$229.30 /1MG
Taille
Request Bulk Quote
Product Information

Inhibiteur efficace de la dipeptidyl-peptidase IV (DPIV).

Synonyms
H-Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu-OH
CAS Number
200203-20-9
Molecular Formula
C 43 H 68 N 10 O 17 S
Molecular Weight
1029.13
MDL Number
MFCD01318807
PubChem ID
155886108
Conditions
Conserver à -0°C.
General Information
Synonyms
H-Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu-OH
CAS Number
200203-20-9
Molecular Formula
C 43 H 68 N 10 O 17 S
Molecular Weight
1029.13
MDL Number
MFCD01318807
PubChem ID
155886108
Conditions
Conserver à -0°C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

HIV-1 tat Protein (1-9) is widely utilized in research focused on

  • Vaccine Development: This protein plays a crucial role in the development of therapeutic vaccines aimed at HIV. Researchers use it to stimulate immune responses, helping to create more effective vaccines.
  • Drug Discovery: It serves as a target for antiviral drug development. By studying its interactions, scientists can identify potential inhibitors that may block HIV replication.
  • Cellular Mechanism Studies: The protein is essential for understanding the molecular mechanisms of HIV infection. It helps researchers investigate how HIV hijacks cellular machinery, leading to new therapeutic strategies.
  • Biomarker Research: HIV-1 tat Protein (1-9) is explored as a potential biomarker for disease progression. Its levels in patients can provide insights into the effectiveness of treatments and the state of the infection.
  • Gene Therapy Applications: This protein is being studied for its role in gene therapy approaches. It can be used to enhance the delivery of therapeutic genes to target cells, improving treatment outcomes for HIV-infected individuals.

Citations